Tape measure or laser? study tests which height method best protects ARDS lungs
NCT ID NCT07595926
First seen Jun 24, 2026 · Last updated Jul 07, 2026 · Updated 3 times
Summary
This study looks at how different ways of measuring height affect ventilator settings and lung injury risk in people with acute respiratory distress syndrome (ARDS). Researchers will measure 39 patients' heights using five methods (stadiometer, visual estimation, tape, laser, and heel-to-knee distance) and adjust the ventilator accordingly. They will then check lung stress and other breathing measures to see which method is safest.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could show which height measurement method is best for setting ventilators in ARDS, potentially reducing lung injury and improving outcomes.
- What could go wrong
- This is a small, early-stage study (39 participants) that only tests short-term effects. It may not lead to changes in practice or apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU Amiens
RECRUITINGAmiens, 80480, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Lung-Opening maneuver change a key injury marker in ARDS?
- Could simply sitting up ease breathing in severe lung failure?
- Could lung fluid proteins reveal a new way to track severe lung injury?
- Could a spirometer test guide breathing support in respiratory failure?
- Which ventilator setting saves more lungs? a Head-to-Head test
- Can a single antibody turn down the immune storm in ARDS?